{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "We aim to determine factors associated with stroke or death at 30 days in the stenting arm of the SAMMPRIS trial."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "We compared patient specific variables, lesion specific variables, procedure specific variables, and FDA approved indications between patients with and without the primary outcome (stroke or death at 30 days)."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "We identified 213 patients; 30 patients (14.1%) met the primary outcome."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Smoking status and lesion length were associated with the primary outcome; the odds of stroke or death for non-smokers vs. smokers (adjusted OR 4.46, 95% CI 1.79\u201311.1, p = 0.001) and with increasing lesion length in millimeters (adjusted OR 1.20, 95% CI 1.02\u20131.39, p = 0.029)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 7,
    "max_score": 25
  },
  "model": "gpt-4o"
}